Insider · CIK 0001808905

ADAMS R MARK

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001808905

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-11	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−2,308 sh	$8.63	−$19.9K	175,361
2023-04-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−817 sh	$8.50	−$6,944.5	177,669
2023-03-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−17.2K sh	$8.60	−$148K	178,486
2023-03-06	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+133K sh	—	—	133,033
2023-03-06	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−6,529 sh	$8.57	−$56K	195,641
2023-03-06	ADPTAdaptive Biotechnologies CorpA Award	Chief Operating Officer	AAward	+88.7K sh	—	—	202,170
2023-01-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−2,130 sh	$8.58	−$18.3K	113,518
2023-01-09	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−995 sh	$8.50	−$8,457.5	115,648
2022-10-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−2,284 sh	$7.13	−$16.3K	116,643
2022-10-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−841 sh	$7.61	−$6,400.01	118,927
2022-07-08	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−2,300 sh	$10.47	−$24.1K	119,768
2022-07-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−825 sh	$9.53	−$7,862.25	122,068
2022-04-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−831 sh	$13.17	−$10.9K	122,893
2022-03-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−1,244 sh	$12.01	−$14.9K	123,724
2022-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+185K sh	—	—	185,338
2022-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Operating Officer	AAward	+74.1K sh	—	—	124,968
2022-01-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−1,021 sh	$23.32	−$23.8K	50,833
2021-10-08	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−1,801 sh	$33.67	−$60.6K	51,854
2021-10-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−1,324 sh	$32.47	−$43K	53,655
2021-07-08	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−2,254 sh	$36.30	−$81.8K	54,979
2021-07-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−871 sh	$39.42	−$34.3K	57,233
2021-06-17	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+14.6K sh	$28.10	+$410K	72,687
2021-06-17	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−14.6K sh	$40.00	−$583K	58,104
2021-06-17	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−14.6K sh	—	—	35,417
2021-06-14	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−8,914 sh	$38.77	−$346K	58,104
2021-04-07	ADPTAdaptive Biotechnologies CorpS Sale	Chief Operating Officer	SSale	−3,586 sh	$42.34	−$152K	67,018
2021-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Operating Officer	AAward	+20.6K sh	—	—	70,604
2021-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+51.5K sh	—	—	51,511
2020-04-06	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2020-04-06	ADPTAdaptive Biotechnologies CorpA Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Apr 124
ADAMS R MARK0001062993-23-009085
SEC(opens sec.gov)
Mar 84
ADAMS R MARK0001062993-23-006327
SEC(opens sec.gov)
Jan 114
ADAMS R MARK0001209191-23-003052
SEC(opens sec.gov)
Oct 114
ADAMS R MARK0001209191-22-053372
SEC(opens sec.gov)
Jul 84
ADAMS R MARK0001209191-22-041730
SEC(opens sec.gov)
Apr 84
ADAMS R MARK0001209191-22-023916
SEC(opens sec.gov)
Mar 84
ADAMS R MARK0001209191-22-017392
SEC(opens sec.gov)
Jan 104
ADAMS R MARK0001209191-22-002766
SEC(opens sec.gov)
Oct 84
ADAMS R MARK0001209191-21-060116
SEC(opens sec.gov)
Jul 84
ADAMS R MARK0001209191-21-046083
SEC(opens sec.gov)

Companies

Adaptive Biotechnologies CorpChief Operating OfficerADPT

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORP. SUITE 200

SEATTLE, WA, 98102